Table 2.
Severe COVID-19 Group N = 35 |
Moderate COVID-19 Group N = 45 |
Control Group N = 40 |
Test | P-value | |
---|---|---|---|---|---|
Oxygen concentration % | F 372.5 |
<0.001 | |||
Mean ±SD | 80.83±3.68 | 85.0±3.03 | 98.93±0.64 | ||
Median (Range) | 80 (75 - 86) | 85 (80- 90) | 98.0 (97 - 99) | ||
Oxygen concentration value | X2 76.75 |
<0.001 | |||
Low | 35 (100%) | 27 (60%) | 0 (0.0%) | ||
Normal | 0 (0.0%) | 18 (40.0%) | 40 (100%) | ||
Ferritin (ng/ ml) | K 5.14 |
<0.001 | |||
Mean ±SD | 552.66±483.67 | 113.13±54.72 | 82.5±33.38 | ||
Median (Range) | 500 (71 - 2000) | 99 (60 - 300) | 76.5 (40 - 200) | ||
Ferritin value | X2 68.08 |
<0.001 | |||
Normal | 10 (28.6%) | 43 (95.6%) | 40 (100%) | ||
High | 25 (71.4%) | 2 (4.4%) | 0 (0.0%) | ||
CRP (mg/L) | K 5.87 |
<0.001 | |||
Mean ±SD | 56.26±23.89 | 23.27±9.11 | 3.18±1.08 | ||
Median (Range) | 57 (20 - 90) | 22 (6 - 40) | 3 (1 - 5) | ||
D -dimer (µg/ml) | K 6.40 |
<0.001 | |||
Mean ±SD | 2.71±1.83 | 0.46±0.25 | 0.37±0.06 | ||
Median (Range) | 2 (0.39 - 6) | 0.40 (0.22 - 1.2) | 0.37 (0.28 - 0.48) | ||
TLC (x103) | K 0.19 |
0.85 | |||
Mean ±SD | 6.49±2.73 | 6.43±2.01 | 8.95±1.70 | ||
Median (Range) | 5.7 (2.6 - 12.0) | 6 (2.6 - 9.6) | 8.7 (6.3 - 11.4) | ||
Hb (gm/dl) | F 0.68 |
0.50 | |||
Mean ±SD | 11.84±1.61 | 12.06±1.31 | 12.15±1.22 | ||
Median (Range) | 11.9 (9.1 - 15.9) | 12.3 (9 - 14.4) | 12.05 (8.5 - 14) | ||
Absolute lymphocytes | K 1.65 |
0.10 | |||
Mean ±SD | 1.38±0.92 | 1.71±0.85 | 2.16±0.54 | ||
Median (Range) | 1.6 (0.19 - 2.9) | 1.8 (0.32 - 3.0) | 2.2 (1.1 - 3) |
F = F test of ANOVA
K = Kruskal Wallis test CRP; C-reactive protein, TLC; total leukocytic count, Hb; hemoglobin
High: elevated above the normal reference value